Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Pfizer in Asia Will Focus on Asia-Specific Diseases and Solutions

publication date: Apr 7, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Pfizer will turn the focus of its Singapore clinical research unit toward Asia-specific diseases. In part, this means the unit will emphasize diseases that are more prevalent in Asia, diseases such as specific forms of cancer. It also means that Pfizer will investigate diseases that are prevalent around the globe, but whose etiology in Asian populations may be different than in the rest of the world. Pfizer cited diabetes as an example of the latter category. More details...

Stock Symbol: (NYSE: PFE)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners